Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-06-011257
Filing Date
2006-02-23
Accepted
2006-02-22 20:00:45
Documents
10
Period of Report
2005-12-28

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-1872_110k.htm 10-K 1900906
2 MATERIAL CONTRACTS a06-1872_1ex10d3.htm EX-10.3 145917
3 MATERIAL CONTRACTS a06-1872_1ex10d9.htm EX-10.9 74237
4 CONSENTS OF EXPERTS AND COUNSEL a06-1872_1ex23d1.htm EX-23.1 3193
5 CONSENTS OF EXPERTS AND COUNSEL a06-1872_1ex23d2.htm EX-23.2 7548
6 POWER OF ATTORNEY a06-1872_1ex24d1.htm EX-24.1 32747
7 302 CERTIFICATION a06-1872_1ex31d1.htm EX-31.1 10850
8 302 CERTIFICATION a06-1872_1ex31d2.htm EX-31.2 10251
9 906 CERTIFICATION a06-1872_1ex32d1.htm EX-32.1 6419
10 906 CERTIFICATION a06-1872_1ex32d2.htm EX-32.2 5713
  Complete submission text file 0001104659-06-011257.txt   2199339
Mailing Address 4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301
Business Address 4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301 303-516-8500
TAPESTRY PHARMACEUTICALS, INC (Filer) CIK: 0000891504 (see all company filings)

EIN.: 841187753 | State of Incorp.: DE | Fiscal Year End: 1229
Type: 10-K | Act: 34 | File No.: 000-24320 | Film No.: 06637461
SIC: 2833 Medicinal Chemicals & Botanical Products